The hunt for a vaccine against malaria in pregnant women has provided an unexpected side benefit for Danish researchers, namely what appears to be an effective weapon against cancer. The scientists behind the vaccine aim for tests on humans within four years.
Danish scientists from the University of Copenhagen and the University of British Columbia (UBC) face a possible breakthrough in the fight against cancer, which may result in a genuine medical treatment for the dreaded disease.
The hunt for a weapon to fight malaria in pregnant women has revealed that, expressed in popular terms, armed malaria proteins can kill cancer. The researchers behind the discovery hope to be able to conduct tests on humans within four years.
In collaboration with cancer researcher Mads Daugaard from the University of British Columbia in Canada, malaria researcher Professor Ali Salanti from the Faculty of Medical Health and Sciences, UCPH, has revealed that the carbohydrate that the malaria parasite attaches itself to in the placenta in pregnant women is identical to a carbohydrate found in cancer cells.
In the laboratory, scientists have created the protein that the malaria parasite uses to adhere to the placenta and added a toxin. This combination of malaria protein and toxin seeks out the cancer cells, is absorbed, the toxin released inside, and then the cancer cells die. This process has been witnessed in cell cultures and in mice with cancer. The discovery has only just been described in an article in the renowned scientific journal Cancer Cell.
“For decades, scientists have been searching for similarities between the growth of a placenta and a tumor. The placenta is an organ, which within a few months grows from only few cells into an organ weighing approx. two pounds, and it provides the embryo with oxygen and nourishment in a relatively foreign environment. In a manner of speaking, tumors do much the same, they grow aggressively in a relatively foreign environment,” says Ali Salanti from the Department of Immunology and Microbiology at the University of Copenhagen.
Ali Salanti’s team is currently testing a vaccine against malaria on humans, and it was in connection with the development of this drug that he discovered that the carbohydrate in the placenta was also present in cancer tumors. Ali Salanti immediately contacted his former fellow student and now cancer researcher, Mads Daugaard, who is head of the Laboratory of Molecular Pathology at the Vancouver Prostate Center at UBC in Canada. In collaboration, the two groups have generated results, which they hope will provide the basis for a drug against cancer.
“We examined the carbohydrate’s function. In the placenta, it helps ensure fast growth. Our experiments showed that it was the same in cancer tumors. We combined the malaria parasite with cancer cells and the parasite reacted to the cancer cells as if they were a placenta and attached itself,” Ali Salanti explains.
The Latest on: Cure for cancer
via Google News
The Latest on: Cure for cancer
- Karnataka Govt Mulls Providing Medicines For Cancer Treatment At Concessional Rateson August 23, 2021 at 7:23 pm
Karnataka Chief Minister Basavaraj Bommai said on Monday, August 23, that the government is considering setting up a society to provide medicines for cancer treatment at concessional rates. He ...
- ‘Govt mulling setting up society to provide medicines for cancer treament at concessional rates’on August 23, 2021 at 7:19 pm
Bengaluru: Karnataka Chief Minister Basavaraj Bommai on Monday said the Government is mulling setting up a society to provide medicines for cancer treatment at concessional rates. He ...
- First-in-kind kidney cancer drug developed at UTSW receives FDA approvalon August 23, 2021 at 6:59 pm
A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a ...
- Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in Chinaon August 23, 2021 at 5:30 pm
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in ...
- 'K'taka mulls to provide medicines for cancer treatment'on August 23, 2021 at 2:18 pm
Chief Minister Basavaraj Bommai said on Monday that the government is mulling to set up a society to provide medicines for cancer treatment at concessional rate ...
- Cholangiocarcinoma Foundation raises more than $76,000 in 2nd Annual Moving for the Cureon August 23, 2021 at 1:29 pm
The Cholangiocarcinoma Foundation (CCF) and TeamCCF sponsored its second athletic event, Moving for the Cure. The virtual fundraiser invited participants from around the world, of any age, and of any ...
- New hope for people with Gastric Canceron August 23, 2021 at 1:16 pm
Dr. Ronan Kelly, Director of the Charles A. Sammons Cancer Center at Baylor University Medical Center, and Michael Ehren, Board President of Debbie’s Dream foundation: Curing Stomach Cancer share ...
- COVID Booster May Benefit Active-Treatment Cancer Patientson August 23, 2021 at 7:27 am
However, IgG titers were statistically significantly lower in the patients with cancer as compared to control persons 4 months after the second vaccine.
- Pfizer to pay $2.26B for cancer treatment developer Trilliumon August 23, 2021 at 6:47 am
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay $18.50 for each share of Trillium Therapeutics Inc., or more than double the stock’s 60 ...
- Cure Cancer Cup Raises $20,000on August 23, 2021 at 6:26 am
REDONDO一 The King Harbor Yacht Club hosted the 29th Annual Cure Cancer Cup in July and raised over $20,000 for Cedars-Sinai Research Lab, according to a press release from the club. There were 24 ...
via Bing News